The driving factors for the drug discovery markets development include the increasing incidence of a broad spectrum of illnesses such as cardiovascular and CNS-related disorders , increasing healthcare spending, and the coming patent expiry of blockbuster drugs.
Globally, the variety of illnesses, mainly cardiovascular disease, infectious diseases, diabetes, and problems associated with the kidneys, has a high incidence. As a result, the growing prevalence of a variety of illnesses among all age groups and its global burden drives demand for drug discovery and its market.
Advanced techniques such as high performance, bioinformatics, and combinatorial chemistry for better identification of drug candidates have been increasingly being used. With evolving technologies, drug discovery has developed considerably, helping the method become more sophisticated, more precise and less time consuming. High-throughput testing is one of the most commonly used drug discovery techniques due to automation, multi-detector readers, imaging hardware and software.
Over the past few years, there has been a rising demand for specialty medicines that are expected to ultimately have a positive effect on the market for small molecule drug discovery, as most specialty medicines are small molecules.
The gradual increase in healthcare spending enables advance the new pharmaceutical technology on a regional basis. Although there is a need for resource redirection with elevated spending, the shift to better usability of drug development healthcare spending is underway.
The Reports Scope:
Drug discovery is a method according to the scope of the study, which aims to identify a compound that is therapeutically helpful for treating and curing illnesses. Typically, a drug discovery effort addresses a biological target that has been shown to play a role in the development of the disease or starts from a molecule with interesting biological activities. In the latest past, with emerging technologies, drug discovery has developed considerably, helping the method become more refined, more precise, and less time consuming.
Drug Discovery Market Trends:
Biologics Drug is the Segment that is Expected to Grow Fastest under Drug Type:
A biologic medication is a product generated from living organisms or containing living organism parts. Biological drugs include a broad range of products from human, animal, or micro-organisms. Biologic medications are the most developed therapies available for the therapy of various illnesses and circumstances. Biological treatments are for autoimmune illnesses, which include treatments for rheumatoid arthritis, psoriasis, ulcerative colitis, Crohns illness, and a variety of associated illnesses, and have continued to see growing geographical use. Biologic drugs are anticipated to be fuelled by developments in oncology, autoimmune, and diabetes treatments, with the oncology and autoimmune industries having specific significant possibilities for biologics.
The increasing use of small molecule drugs for chronic disease treatment leads to increased market demand for these drugs. In addition, small molecule drugs dominate biologics in the current healthcare market due to the aforementioned factors.
Asia-pacific Is Expected to grow over the Forecast Period with the Fastest Growth:
Due to the existence of skilled labor at an affordable price, the increase in disposable income, and favourable public policies that contribute to market growth, Asia Pacific is the fastest growing region. The outsourcing companies in the Chinese region have also experienced phenomenal growth over the past decade, which has complemented the R&D restructuring that has taken place. As a result, the drug discovery market is anticipated to expand due to the big deals of pharmaceutical companies and more study being performed.
The market studied has different pharmaceutical companies that invest billions of dollars in artificial intelligence AI to make the process of drug discovery significantly faster and cost-effective. Pharmaceutical and biotech businesses are growing their collaboration with contract growth and production organisations, thus playing a vital role in fresh drug growth and innovation.
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porters Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.4. SWOT Analysis
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing Prevalence of a Wide Range of Diseases
4.1.2. Rising Healthcare Expenditure
4.1.3. Technological Advancements and Innovations
4.2. Market Restraints
4.2.1. Huge Capital Investment with Low Profit Margins
4.2.2. Stringent Government Regulations
4.3. Market Opportunities
4.4. Market Challenges
CHAPTER 5 DRUG DISCOVERY MARKET – BY DRUG TYPE
5.1. Small Molecule Drugs
5.2. Biologic Drugs
CHAPTER 6 DRUG DISCOVERY MARKET – BY TECHNOLOGY
6.1. High Throughput Screening
6.3. Combinatorial Chemistry
6.5. Other Technologies
CHAPTER 7 DRUG DISCOVERY MARKET – BY END USER
7.1. Pharmaceutical Companies
7.2. Contract Research Organizations CROs
7.3. Other End Users
CHAPTER 8 DRUG DISCOVERY MARKET – BY GEOGRAPHY
8.2. North America
8.2.4. Costa Rica
8.3. South America
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.6. Middle East & Africa
8.6.2. Saudi Arabia
8.6.6. South Africa
CHAPTER 9 DRUG DISCOVERY MARKET – COMPANY PROFILES
9.1. Shimadzu Corp.
9.2. AstraZeneca PLC
9.3. Abbott Laboratories Inc.
9.4. Bayer AG
9.5. Agilent Technologies Inc.
9.6. Eli Lilly and Company
9.7. F. Hoffmann-La Roche Ltd
9.8. Merck & Co. Inc.
9.9. GlaxoSmithKline PLC
9.10. Pfizer Inc.
CHAPTER 10 DRUG DISCOVERY MARKET – COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
Need More information
Why to choose PMR
PMR Market Research
Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.
- Industrial ...
- Business ....
- Consumer ....
- Peer ....
Planet Market Reports added Latest and detailed market study report that focuses on “DRUG DISCOVERY MARKET ; Market" Which offers essential information based on fresh ideas into DRUG DISCOVERY MARKET ; Market industry along with unique market analysis which covers current top Manufactures in DRUG DISCOVERY MARKET ; Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim DRUG DISCOVERY MARKET ; Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.